Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
2.89
40.90
1,415.22%
Share Warrants & Outstandings
Total Reserve
19.05
323.72
-304.67
-94.12%
Shareholder's Funds
62.84
326.61
-263.77
-80.76%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
0.00
3.11
0.00%
Secured Loans
1.64
0.00
1.64
0.00%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
-3.11
6.52
209.65%
Other Long Term Liabilities
0.13
1.89
-1.76
-93.12%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
8.30
-8.30
-100.00%
Total Non-Current Liabilities
6.65
7.08
-0.43
-6.07%
Current Liabilities
Trade Payables
9.22
69.04
-59.82
-86.65%
Other Current Liabilities
4.27
13.20
-8.93
-67.65%
Short Term Borrowings
1.06
0.00
1.06
0.00%
Short Term Provisions
2.74
2.34
0.40
17.09%
Total Current Liabilities
17.28
84.58
-67.30
-79.57%
Total Liabilities
86.77
418.28
-331.51
-79.26%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
79.36
-35.94
-45.29%
Less: Accumulated Depreciation
24.03
31.83
-7.80
-24.51%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
47.52
-28.12
-59.18%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
16.20
-14.25
-87.96%
Intangible assets under development
0.00
0.05
-0.05
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.05
-0.05
-100.00%
Long Term Loans & Advances
0.00
20.31
-20.31
-100.00%
Other Non Current Assets
0.00
41.60
-41.60
-100.00%
Total Non-Current Assets
21.34
127.61
-106.27
-83.28%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
9.95
27.26
-17.31
-63.50%
Sundry Debtors
8.77
55.82
-47.05
-84.29%
Cash and Bank
12.12
83.16
-71.04
-85.43%
Other Current Assets
20.17
1.06
19.11
1,802.83%
Short Term Loans and Advances
14.42
123.37
-108.95
-88.31%
Total Current Assets
65.43
290.67
-225.24
-77.49%
Net Current Assets (Including Current Investments)
48.14
206.09
-157.95
-76.64%
Total Current Assets Excluding Current Investments
65.43
290.67
-225.24
-77.49%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
418.28
-331.51
-79.26%
Contingent Liabilities
1.40
15.77
-14.37
-91.12%
Total Debt
4.18
0.00
4.18
0.00%
Book Value per share (adjusted)
1.44
112.97
-111.53
-98.73%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024
